Literature DB >> 8806738

Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells.

A Schneider1, W A Schmalix, V Siruguri, E M de Groene, G J Horbach, B Kleingeist, D Lang, R Böcker, C Belloc, P Beaune, H Greim, J Doehmer.   

Abstract

V79 Chinese hamster cells were constructed for stable expression of human cytochrome P450 3A4 with and without coexpression of human NADPH-cytochrome P450 oxidoreductase. Expression of the cDNAs was shown by Northern and Western analyses. Activity was tested by 6 beta-hydroxylation of testosterone for cytochrome P450 3A4 and by cytochrome c reduction for NADPH-cytochrome P450 reductase. Five V79 cell lines were obtained expressing cytochrome P450 3A4, human NADPH-cytochrome P450 oxidoreductase, and both. Cytochrome P450 3A4 activity depended highly on cytochrome P450 reductase activity, with lowest activity when only the parental Chinese hamster cytochrome P450 reductase was present, 5- and 10-fold higher when coexpressed with the human NADPH-cytochrome P450 reductase. Correspondingly, cytotoxic and genotoxic potency of aflatoxin B1 was increased by orders of magnitudes when human cytochrome P450 3A4 was coexpressed with the human NADPH-cytochrome P450 reductase. The effect of NADPH-cytochrome P450 reductase coexpression on cytochrome P450 3A4 activity was also tested by nifedipine oxidation and midazolam hydroxylation. Nifedipine oxidation was increased about 10-fold, 1-hydroxylation of midazolam and 4-hydroxylation of midazolam were increased 15-fold.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806738     DOI: 10.1006/abbi.1996.0345

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein.

Authors:  C Brimer; J T Dalton; Z Zhu; J Schuetz; K Yasuda; E Vanin; M V Relling; Y Lu; E G Schuetz
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

2.  Chemical toxicity testing in vitro using cytochrome P450-expressing cell lines, such as human CYP1B1.

Authors:  Robert Landsiedel; Eric Fabian; Tewes Tralau; Andreas Luch
Journal:  Nat Protoc       Date:  2011-04-28       Impact factor: 13.491

3.  Molecular cloning and recombinant expression of cytochrome P450 CYP6B6 from Helicoverpa armigera in Escherichia coli.

Authors:  Xiaoning Liu; Lei Zhang; Xuetao Zhang; Gao Xiwu
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

4.  Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes.

Authors:  L M Scott; P Durant; S Leone-Kabler; C E Wood; T C Register; A Townsend; J M Cline
Journal:  J Steroid Biochem Mol Biol       Date:  2008-10-08       Impact factor: 4.292

5.  Heterologous expression of equine CYP3A94 and investigation of a tunable system to regulate co-expressed NADPH P450 oxidoreductase levels.

Authors:  Ramona Dettwiler; Andrea L Schmitz; Philippe Plattet; Jana Zielinski; Meike Mevissen
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

6.  Functional impact of cytochrome P450 3A (CYP3A) missense variants in cattle.

Authors:  Mery Giantin; Minna Rahnasto-Rilla; Roberta Tolosi; Lorena Lucatello; Marianna Pauletto; Giorgia Guerra; Francesca Pezzato; Rosa M Lopparelli; Roberta Merlanti; Paolo Carnier; Francesca Capolongo; Paavo Honkakoski; Mauro Dacasto
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.